Skip to main content

Table 4 Two-year and five-year survival for RIGS with 125I-B72.3 monoclonal antibody

From: A comprehensive overview of radioguided surgery using gamma detection probe technology

PATIENT
GROUP
SURVIVAL: 2-YEAR
(% PATIENTS)
SURVIVAL: 5-YEAR
(% PATIENTS)
RIGS resectable 95% 60%
Traditional nonresectable 36% 0%
RIGS nonresectable 57% 0%